Victrex plc (LON:VCT) Insider Urmi Prasad Richardson Buys 100 Shares

Posted by Grant Hamersma on Mar 24th, 2025

Victrex plc (LON:VCT – Get Free Report) insider Urmi Prasad Richardson acquired 100 shares of Victrex stock in a transaction that occurred on Friday, March 21st. The shares were bought at an average price of GBX 958 ($12.37) per share, with a total value of £958 ($1,237.09).

Victrex Stock Down 1.7 %

Shares of Victrex stock opened at GBX 949 ($12.25) on Monday. The business’s fifty day moving average price is GBX 981.10 and its two-hundred day moving average price is GBX 966.18. The company has a debt-to-equity ratio of 10.93, a current ratio of 4.39 and a quick ratio of 1.99. The company has a market capitalization of £827.83 million, a P/E ratio of 26.96, a PEG ratio of 1.92 and a beta of 0.69. Victrex plc has a 1-year low of GBX 816 ($10.54) and a 1-year high of GBX 1,368 ($17.67).

Victrex (LON:VCT – Get Free Report) last announced its earnings results on Tuesday, December 24th. The company reported GBX 51.70 ($0.67) earnings per share for the quarter. Victrex had a return on equity of 6.67% and a net margin of 10.81%. As a group, research analysts forecast that Victrex plc will post 73.1078905 EPS for the current year.

Victrex Increases Dividend

The company also recently disclosed a dividend, which was paid on Friday, February 21st. Stockholders of record on Thursday, January 23rd were paid a GBX 46.14 ($0.60) dividend. This represents a dividend yield of 5.26%. The ex-dividend date of this dividend was Thursday, January 23rd. This is an increase from Victrex’s previous dividend of $13.42. Victrex’s payout ratio is currently 170.47%.

Analyst Upgrades and Downgrades

Separately, Berenberg Bank cut their target price on Victrex from GBX 1,290 ($16.66) to GBX 1,170 ($15.11) and set a “hold” rating on the stock in a research note on Wednesday, December 4th.

Read Our Latest Stock Analysis on Victrex

Victrex Company Profile

(Get Free Report)

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.